These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 21751791

  • 1. Evolution from a natural flavones nucleus to obtain 2-(4-Propoxyphenyl)quinoline derivatives as potent inhibitors of the S. aureus NorA efflux pump.
    Sabatini S, Gosetto F, Manfroni G, Tabarrini O, Kaatz GW, Patel D, Cecchetti V.
    J Med Chem; 2011 Aug 25; 54(16):5722-36. PubMed ID: 21751791
    [Abstract] [Full Text] [Related]

  • 2. From phenothiazine to 3-phenyl-1,4-benzothiazine derivatives as inhibitors of the Staphylococcus aureus NorA multidrug efflux pump.
    Sabatini S, Kaatz GW, Rossolini GM, Brandini D, Fravolini A.
    J Med Chem; 2008 Jul 24; 51(14):4321-30. PubMed ID: 18578473
    [Abstract] [Full Text] [Related]

  • 3. Re-evolution of the 2-phenylquinolines: ligand-based design, synthesis, and biological evaluation of a potent new class of Staphylococcus aureus NorA efflux pump inhibitors to combat antimicrobial resistance.
    Sabatini S, Gosetto F, Iraci N, Barreca ML, Massari S, Sancineto L, Manfroni G, Tabarrini O, Dimovska M, Kaatz GW, Cecchetti V.
    J Med Chem; 2013 Jun 27; 56(12):4975-89. PubMed ID: 23710549
    [Abstract] [Full Text] [Related]

  • 4. Synthesis of amides from (E)-3-(1-chloro-3,4-dihydronaphthalen-2-yl)acrylic acid and substituted amino acid esters as NorA efflux pump inhibitors of Staphylococcus aureus.
    Rath SK, Singh S, Kumar S, Wani NA, Rai R, Koul S, Khan IA, Sangwan PL.
    Bioorg Med Chem; 2019 Jan 15; 27(2):343-353. PubMed ID: 30552006
    [Abstract] [Full Text] [Related]

  • 5. Novel structural analogues of piperine as inhibitors of the NorA efflux pump of Staphylococcus aureus.
    Kumar A, Khan IA, Koul S, Koul JL, Taneja SC, Ali I, Ali F, Sharma S, Mirza ZM, Kumar M, Sangwan PL, Gupta P, Thota N, Qazi GN.
    J Antimicrob Chemother; 2008 Jun 15; 61(6):1270-6. PubMed ID: 18334493
    [Abstract] [Full Text] [Related]

  • 6. 1-(1H-indol-3-yl)ethanamine derivatives as potent Staphylococcus aureus NorA efflux pump inhibitors.
    Hequet A, Burchak ON, Jeanty M, Guinchard X, Le Pihive E, Maigre L, Bouhours P, Schneider D, Maurin M, Paris JM, Denis JN, Jolivalt C.
    ChemMedChem; 2014 Jul 15; 9(7):1534-45. PubMed ID: 24677763
    [Abstract] [Full Text] [Related]

  • 7. Amino acid amides of piperic acid (PA) and 4-ethylpiperic acid (EPA) as NorA efflux pump inhibitors of Staphylococcus aureus.
    Wani NA, Singh S, Farooq S, Shankar S, Koul S, Khan IA, Rai R.
    Bioorg Med Chem Lett; 2016 Sep 01; 26(17):4174-8. PubMed ID: 27503686
    [Abstract] [Full Text] [Related]

  • 8. Capsaicin, a novel inhibitor of the NorA efflux pump, reduces the intracellular invasion of Staphylococcus aureus.
    Kalia NP, Mahajan P, Mehra R, Nargotra A, Sharma JP, Koul S, Khan IA.
    J Antimicrob Chemother; 2012 Oct 01; 67(10):2401-8. PubMed ID: 22807321
    [Abstract] [Full Text] [Related]

  • 9. Searching for Novel Inhibitors of the S. aureus NorA Efflux Pump: Synthesis and Biological Evaluation of the 3-Phenyl-1,4-benzothiazine Analogues.
    Felicetti T, Cannalire R, Burali MS, Massari S, Manfroni G, Barreca ML, Tabarrini O, Schindler BD, Sabatini S, Kaatz GW, Cecchetti V.
    ChemMedChem; 2017 Aug 22; 12(16):1293-1302. PubMed ID: 28598572
    [Abstract] [Full Text] [Related]

  • 10. Structural Modifications of the Quinolin-4-yloxy Core to Obtain New Staphylococcus aureus NorA Inhibitors.
    Cannalire R, Mangiaterra G, Felicetti T, Astolfi A, Cedraro N, Massari S, Manfroni G, Tabarrini O, Vaiasicca S, Barreca ML, Cecchetti V, Biavasco F, Sabatini S.
    Int J Mol Sci; 2020 Sep 24; 21(19):. PubMed ID: 32987835
    [Abstract] [Full Text] [Related]

  • 11. Thiazolidinedione and thiazole derivatives potentiate norfloxacin activity against NorA efflux pump over expression in Staphylococcus aureus 1199B strains.
    Pereira PS, Lima MDCA, Neto PPM, Oliveira-Tintino CDM, Tintino SR, Menezes IRA, de Oliveira JF, Marchand P, Coutinho HDM, Rodrigues MDD, da Silva TG.
    Bioorg Med Chem; 2019 Sep 01; 27(17):3797-3804. PubMed ID: 31320212
    [Abstract] [Full Text] [Related]

  • 12. 1,3,4-oxadiazole conjugates of capsaicin as potent NorA efflux pump inhibitors of Staphylococcus aureus.
    Naaz F, Khan A, Kumari A, Ali I, Ahmad F, Ahmad Lone B, Ahmad N, Ali Khan I, Rajput VS, Grover A, Shafi S.
    Bioorg Chem; 2021 Aug 01; 113():105031. PubMed ID: 34089943
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of the NorA efflux pump of S. aureus by (Z)-5-(4-Fluorobenzylidene)-Imidazolidines.
    Faillace MS, Alves Borges Leal AL, Araújo de Oliveira Alcântara F, Ferreira JHL, de Siqueira-Júnior JP, Sampaio Nogueira CE, Barreto HM, Peláez WJ.
    Bioorg Med Chem Lett; 2021 Jan 01; 31():127670. PubMed ID: 33161124
    [Abstract] [Full Text] [Related]

  • 14. Discovery of novel dihydronaphthalene-imidazole ligands as potential inhibitors of Staphylococcus aureus multidrug resistant NorA efflux pump: A combination of experimental and in silico molecular docking studies.
    A Malik A, Dangroo NA, Kaur P, Attery S, A Rather M, Khan A, Ara T, Nandanwar H.
    Microb Pathog; 2024 May 01; 190():106627. PubMed ID: 38521473
    [Abstract] [Full Text] [Related]

  • 15. Boronic species as promising inhibitors of the Staphylococcus aureus NorA efflux pump: study of 6-substituted pyridine-3-boronic acid derivatives.
    Fontaine F, Héquet A, Voisin-Chiret AS, Bouillon A, Lesnard A, Cresteil T, Jolivalt C, Rault S.
    Eur J Med Chem; 2015 May 05; 95():185-98. PubMed ID: 25817769
    [Abstract] [Full Text] [Related]

  • 16. C-2 phenyl replacements to obtain potent quinoline-based Staphylococcus aureus NorA inhibitors.
    Felicetti T, Mangiaterra G, Cannalire R, Cedraro N, Pietrella D, Astolfi A, Massari S, Tabarrini O, Manfroni G, Barreca ML, Cecchetti V, Biavasco F, Sabatini S.
    J Enzyme Inhib Med Chem; 2020 Dec 05; 35(1):584-597. PubMed ID: 31992093
    [Abstract] [Full Text] [Related]

  • 17. First identification of boronic species as novel potential inhibitors of the Staphylococcus aureus NorA efflux pump.
    Fontaine F, Hequet A, Voisin-Chiret AS, Bouillon A, Lesnard A, Cresteil T, Jolivalt C, Rault S.
    J Med Chem; 2014 Mar 27; 57(6):2536-48. PubMed ID: 24499135
    [Abstract] [Full Text] [Related]

  • 18. Repurposing Approved Drugs as Fluoroquinolone Potentiators to Overcome Efflux Pump Resistance in Staphylococcus aureus.
    Mahey N, Tambat R, Chandal N, Verma DK, Thakur KG, Nandanwar H.
    Microbiol Spectr; 2021 Dec 22; 9(3):e0095121. PubMed ID: 34908453
    [Abstract] [Full Text] [Related]

  • 19. Synthesis, biological evaluation and computational studies of acrylohydrazide derivatives as potential Staphylococcus aureus NorA efflux pump inhibitors.
    Kumar G, Goutami Godavari A, Tambat R, Kumar S, Nandanwar H, Elizabeth Sobhia M, Jachak SM.
    Bioorg Chem; 2020 Nov 22; 104():104225. PubMed ID: 32992278
    [Abstract] [Full Text] [Related]

  • 20. New C-6 functionalized quinoline NorA inhibitors strongly synergize with ciprofloxacin against planktonic and biofilm growing resistant Staphylococcus aureus strains.
    Felicetti T, Cedraro N, Astolfi A, Cernicchi G, Mangiaterra G, Vaiasicca S, Massari S, Manfroni G, Barreca ML, Tabarrini O, Biavasco F, Cecchetti V, Vignaroli C, Sabatini S.
    Eur J Med Chem; 2022 Nov 05; 241():114656. PubMed ID: 35963131
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.